Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q3 2014 · 10-Q
Revenue$4.17B$4.17B+30.7% vs Q3 2013 Net income—
EPS Diluted$1.17$1.17+36.0% vs Q3 2013 Gross Profit$1,933,600,000+43.5% Operating Income$640,300,000+63.3%
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$676,000,000+33.7% Free Cash Flowderived$585,300,000+30.3% Margins · derivedGross margin46.4%+4.1 pt vs Q3 2013
Operating margin15.3%+3.1 pt vs Q3 2013
ended Sep 27, 2014 · filed Oct 31, 2014 · 34 d after period end